Boiron SA (BOI) AI Stock Analysis

Boiron SA

(Paris:BOI)

Select Model

Rating:68Neutral

Price Target:EUR 19.00▲(1.60% Upside)

Action:reiterated

Date:09/24/26

Solid balance sheet strength and attractive valuation are the primary positive drivers, partially offset by weak technical momentum.

Positive Factors

Low LeverageVery low leverage gives Boiron substantial financial flexibility and reduces the burden of interest and refinancing costs. This conservative capital structure can help the company withstand operating volatility while preserving capacity to invest, maintain products, or return cash to shareholders.

Negative Factors

Severe Revenue ContractionThe severe reported 2025 revenue contraction and broader history of uneven declines weaken visibility into Boiron’s underlying demand. Persistent top-line instability can limit operating leverage, complicate planning, and make future earnings less dependable even when profitability improves.

Boiron SA (BOI) vs. iShares MSCI France ETF (EWQ)

Market Cap: EUR 323.81M
Dividend Yield: 7.22%
Average Volume (3M): 4,303
Price to Earnings (P/E): 12.6
Beta (1Y): 0.23
Revenue Growth: -1.80%
EPS Growth: 35.22%
Country: France
Employees: 2,623
Sector: General
Sector Strength: 55
Industry: Drug Manufacturers - Specialty & Generic

Boiron SA Business Overview & Revenue Model

Company Description

Boiron S.A. is a global pharmaceutical company specializing in the production and distribution of homeopathic remedies across France, Europe, North America, and other international markets. Its extensive product portfolio encompasses a range of non-p...

How the Company Makes Money

Boiron makes money primarily by selling its health products—most notably homeopathic medicines—through wholesale and retail distribution networks, with pharmacies as a key channel. Revenue is generated from the commercial sale of packaged remedies an...

Boiron SA Financial Statement Overview

Summary

Balanced profile with strong balance sheet (low debt, robust equity) offset by inconsistent revenue growth and fluctuating free cash flow.

Income Statement

65Positive

Balance Sheet

80Positive

Cash Flow

70Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	495.78M	501.11M	487.56M	493.25M	534.24M	455.20M
Gross Profit	357.93M	365.73M	358.76M	358.08M	379.73M	327.62M
EBITDA	56.66M	66.30M	45.46M	73.67M	91.33M	78.75M
Net Income	26.19M	32.64M	11.34M	35.83M	44.67M	28.56M
Balance Sheet
Total Assets	568.69M	602.81M	576.33M	590.20M	789.49M	770.70M
Cash, Cash Equivalents and Short-Term Investments	50.67M	79.34M	64.71M	74.04M	250.94M	234.50M
Total Debt	23.80M	31.48M	14.97M	13.70M	22.17M	12.61M
Total Liabilities	193.25M	210.03M	198.15M	198.70M	232.15M	238.93M
Stockholders Equity	375.42M	392.76M	378.14M	393.66M	557.62M	531.74M
Cash Flow
Free Cash Flow	25.76M	29.72M	33.77M	27.47M	41.51M	13.46M
Operating Cash Flow	43.03M	53.24M	42.17M	45.49M	60.10M	33.88M
Investing Cash Flow	-25.27M	-23.39M	-18.36M	-22.93M	-15.28M	-11.92M
Financing Cash Flow	-29.86M	-24.39M	-27.85M	-198.41M	-28.99M	-22.00M

Boiron SA Technical Analysis

Technical Analysis SentimentNeutral

Last Price18.70

Price Trends

50DMA21.47Negative

100DMA24.35Negative

200DMA25.36Negative

Market Momentum

MACD-0.74Negative

RSI44.63Neutral

STOCH70.84Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:BOI, the sentiment is Neutral. The current price of 18.70 is above the 20-day moving average (MA) of 18.12, below the 50-day MA of 21.47, and below the 200-day MA of 25.36, indicating a neutral trend. The MACD of -0.74 indicates Negative momentum. The RSI at 44.63 is Neutral, neither overbought nor oversold. The STOCH value of 70.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FR:BOI.

Boiron SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

FR:BOI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:IPN	71Outperform	EUR 13.04B	25.42	11.33%	1.02%	13.63%	14.45%
FR:BOI	68Neutral	EUR 327.60M	12.55	6.82%	7.22%	-1.80%	35.22%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
FR:VLA	44Neutral	EUR 466.70M	-2.73	-152.15%	―	-27.19%	-117.39%
FR:DBV	40Underperform	EUR 534.36M	-3.16	-121.83%	―	―	45.11%
FR:AB	39Underperform	EUR 52.22M	-6.72	27.28%	―	12.66%	44.01%

* General Sector Average

Performance Comparison

FR:BOI and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
FR:BOI	Boiron SA	18.70	-7.98	-29.92%
FR:DBV	Dbv Technologies SA (UK)	1.70	-0.77	-31.17%
FR:IPN	Ipsen	157.60	36.39	30.02%
FR:ALCOX	Nicox SA	0.30	-0.04	-12.06%
FR:VLA	Valneva (0OB3)	2.45	-1.44	-37.04%
FR:AB	Ab Science	0.54	-0.64	-54.31%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 24, 2026

Boiron SA AI Stock Analysis